PEGylation
(i.e., attachment of polyethylene-glycol) of carbon
nanotubes (CNTs) is one of the most widely used strategies to improve
its biocompatibility and aqueous dispersion stability, which are critical
for their successful clinical application. However, PEGylation of
nanomaterials has recently been associated with production of anti-PEG
antibody, low cellular uptake, and degradation. Herein, we explore
surface functionalization of CNTs using the bovine-milk-derived protein
succinylated β-lactoglobuline (Sblg) as an alternative strategy
to PEGylation. The aqueous dispersion stability, in vitro cell uptake
and biocompatibility of Sblg-functionalized multiwalled CNTs (Sblg-f-MWCNTs)
was compared to PEGylated MWCNTs (PEG-f-MWCNTs). The surface functionalization
with Sblg was found to improve the IC50 values of CNTs by ∼5-
to 6-fold in comparison with pristine CNTs in various cell lines.
Both Sblg-f-MWCNTs and PEG-f-MWCNTs improved the aqueous colloidal
stability of CNTs, which remained suspended for a period of one month.
Our study concluded that the Sblg provides a cost-effective alternative
to the PEG-based CNT functionalization with significant improvement
in the biocompatibility and dispersion stability of CNTs.